Natixis Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-959
| Closed | -$371K | – | 1513 |
|
|
2022
Q4 | $371K | Buy |
959
+6
| +0.6% | +$2.32K | ﹤0.01% | 1360 |
|
|
2022
Q3 | $321K | Buy |
953
+34
| +4% | +$11.5K | ﹤0.01% | 1370 |
|
|
2022
Q2 | $302K | Sell |
919
-136
| -13% | -$44.7K | ﹤0.01% | 1376 |
|
|
2022
Q1 | $461K | Buy |
1,055
+531
| +101% | +$232K | ﹤0.01% | 1301 |
|
|
2021
Q4 | $230K | Buy |
524
+8
| +2% | +$3.51K | ﹤0.01% | 1345 |
|
|
2021
Q3 | $287K | Sell |
516
-115
| -18% | -$64K | ﹤0.01% | 1274 |
|
|
2021
Q2 | $324K | Buy |
631
+214
| +51% | +$110K | ﹤0.01% | 1272 |
|
|
2021
Q1 | $326K | Sell |
417
-2
| -0.5% | -$1.56K | ﹤0.01% | 1223 |
|
|
2020
Q4 | $228K | Buy |
+419
| New | +$228K | ﹤0.01% | 1199 |
|